Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancer.
Koh YW, Lee HJ, Lee JW, Kang J, Gong G
Purpose
The purpose of this paper was to compare the determination of human epidermal growth factor receptor 2 (HER2) status by single- and dual-color silver-enhanced in situ hybridization (SISH) and fluorescence in situ hybridization (FISH) in invasive breast carcinoma specimens.
Conclusion
High HER2 status concordance rates were demonstrated between dual-color SISH and FISH or single-color SISH.
Studies (1)
Purpose
The purpose of this study was to compare the determination of HER2 status by single- and dual-color SISH and FISH in invasive breast carcinoma specimens. Discrepant cases were also assessed by immunohistochemistry (IHC).
Summary of Findings
High HER2 status concordance rates were demonstrated between dual-color SISH and FISH (141/146 cases, 97%) and dual-color SISH and single-color SISH (142/146 cases, 97%). Of the 7 cases showing any discordance between analytical methods, HER2 status determined by IHC was in concordance with the FISH results in 5 cases.
Biospecimens
TissueBreastPreservation Types
FormalinDiagnoses
NeoplasticCarcinomaPlatforms
DNAIn situ hybridizationDNATissue microarrayDNAFISHProteinImmunohistochemistryProteinTissue microarrayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) In situ hybridization Specific Technology platform Dual-color SISHFISHImmunohistochemistrySingle-color SISH